The timing and sequencing of EGFR TKI in relation to ICIs is important, as there is concern regarding increased toxicity when using TKI with or following an ICI in EGFRm NSCLC [39,41,42,59,60]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.